History
  • No items yet
midpage
Global Discovery Biosciences Corporation v. Douglas S. Harrington
CA No. 2022-1132-SG
Del. Ch.
Dec 1, 2023
Read the full case

Background:

  • Global Discovery Biosciences (Global) was founded to commercialize the PULS cardiac test after seed funding from investor Dr. Khalid (via Trivalley), who ultimately held a 55% ownership interest.
  • Dr. Douglas Harrington, Global’s founder, chairman and CEO, created and controlled related entities (ARK, Predictive Health/Smart Health, Morningstar) and allegedly transferred Global’s assets — including the PULS IP, lab space, equipment, employees, and revenue streams — into those entities.
  • Khalid and Trivalley sought inspection and then removed the prior Global board by written consent; a Delaware Chancery action later confirmed their majority ownership and appointed new directors.
  • Harrington, after being removed, caused Global to file bankruptcy; schedules revealed Predictive Health (Smart Health) as a major unsecured creditor and transfers of IP; the bankruptcy petition was later dismissed and control returned to the new directors.
  • Global filed an amended complaint alleging breach of fiduciary duty, aiding and abetting, conversion, DUTSA misappropriation, conspiracy, tortious interference, usurpation of corporate opportunity and other claims; defendants moved to dismiss. This opinion resolves portions of that motion.

Issues:

Issue Plaintiff's Argument Defendant's Argument Held
Fraud (Count III) — misrepresentation re: ownership/licensing Global: Smart Health falsely claimed ownership of the PULS and induced Global to enter a license Defendants: Controller cannot fraudulently induce himself; legal impossibility Granted dismissal — fraud fails because Global, acting through Harrington, could not justifiably rely on representations he caused Smart Health to make to Global
Civil conspiracy (Count IV) — combination to misappropriate assets Global: Harrington, Nuñez, Smart Health, ARK (and VPEG) conspired to divert assets and revenues Defendants: A corporation cannot conspire with its agents; insufficient specificity re: ARK and VPEG Denied dismissal — conspiracy adequately pled at this stage; Harrington’s knowledge may be imputed to ARK and VPEG is in default
Tortious interference (Count VII) — with contracts and prospective relations Global: Smart Health usurped PULS and interfered with existing/prospective contracts and opportunities Defendants: No breach of identified contracts; no particularized prospective opportunities pleaded Granted dismissal — fails to plead a breach of existing contracts or specific prospective business opportunities
Breach of fiduciary duty — bankruptcy filing in bad faith (Count X) Global: Harrington breached duties by causing an unauthorized, bad-faith bankruptcy filing to evade litigation/judgment Defendants: Bankruptcy Code preempts state-law claims; collateral estoppel based on bankruptcy court rulings Denied dismissal — preemption question requires further record; collateral estoppel inapplicable because bankruptcy court did not finally adjudicate bad-faith issue on the merits
Usurpation of corporate opportunity (Count XI) Global: Smart Health is developing tests that were within Global’s line of business and thus misappropriated corporate opportunities Defendants: Insufficient facts that opportunity existed or that Global could exploit it financially Denied dismissal — pleadings suffice at 12(b)(6): opportunity broadly within Global’s line of business and financial ability alleged (fact questions for later)

Key Cases Cited

  • Savor, Inc. v. FMR Corp., 812 A.2d 894 (Del. 2002) (12(b)(6) standard; accept well-pleaded facts and draw inferences for non-movant)
  • Windsor I, LLC v. CWCapital Asset Mgmt. LLC, 238 A.3d 863 (Del. 2020) (conclusory allegations are insufficient without supporting facts)
  • Vanderbilt Income & Growth Assoc., LLC v. Arvida/JMB Managers, Inc., 691 A.2d 609 (Del. 1996) (referenced for documents incorporated by reference in pleadings)
  • DCV Holdings, Inc. v. Conagra, Inc., 889 A.2d 954 (Del. 2005) (elements required to plead common-law fraud)
  • Nelson Radio & Supply Co. v. Motorola, Inc., 200 F.2d 911 (5th Cir. 1952) (a corporation generally cannot conspire with its agents)
  • Irwin & Leighton, Inc. v. W.M. Anderson Co., 532 A.2d 983 (Del. Ch. 1987) (elements of tortious interference with contract)
  • DeBonaventura v. Nationwide Mut. Ins. Co., 419 A.2d 942 (Del. Ch. 1980) (elements of tortious interference with prospective business relations)
  • Norman v. State, 976 A.2d 843 (Del. 2009) (doctrine of collateral estoppel and its prerequisites)
  • Ashe v. Swenson, 397 U.S. 436 (U.S. 1970) (foundational Supreme Court authority on issue preclusion)
  • McGowan v. Ferro, 859 A.2d 1012 (Del. Ch. 2004) (elements for misappropriation of corporate opportunity)
  • Broz v. Cellular Info. Sys., Inc., 673 A.2d 148 (Del. 1996) (corporate opportunity doctrine principles)
Read the full case

Case Details

Case Name: Global Discovery Biosciences Corporation v. Douglas S. Harrington
Court Name: Court of Chancery of Delaware
Date Published: Dec 1, 2023
Citation: CA No. 2022-1132-SG
Docket Number: CA No. 2022-1132-SG
Court Abbreviation: Del. Ch.